)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Bicara Therapeutics
Bicara Therapeutics (BCAX) investor relations material
Bicara Therapeutics TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.TD Cowen 46th Annual Health Care Conference summary2 Mar, 2026
Strategic program updates and clinical development
Lead program FICERA targets EGFR and TGF-beta, overcoming prior delivery limitations to the tumor microenvironment.
FORTIFY trial in HPV-negative recurrent metastatic head and neck cancer is progressing, with global site expansion and strong enrollment momentum.
FDA alignment achieved for 1,500 mg weekly dose; phase III component underway with 2:1 randomization versus pembrolizumab monotherapy.
Commercial infrastructure buildout planned for 2026, with launch targeted for 2028.
Additional capital raised to support commercial build and critical hires.
Clinical data highlights and efficacy
FICERA shows a confirmed overall response rate of 54%, with 21% complete response and rapid median time to response of 1.4 months.
High response rates observed across all CPS scores and tumor sizes, with a median duration of response of 21.7 months.
Depth and durability of response increase with higher doses, with 2,000 mg every two weeks showing median depth of 100%.
Tolerability profile includes expected EGFR and TGF-beta related adverse events, such as acneiform rash and transient mucosal bleeds.
Maintenance dosing phase planned to synchronize with pembrolizumab every three weeks.
Regulatory and competitive landscape
FDA supports 1,500 mg dose selection, granting Breakthrough designation based on open-label data.
Accelerated approval filing will require doubling control arm response rate; confidence in meeting FDA thresholds based on pooled data.
Overall survival benefit expected, with trial powered for a clinically meaningful two to three-month increase.
Competitive landscape includes amivantamab and other regimens, but FICERA aims to differentiate on efficacy, safety, and dosing convenience.
Ficerafusp alfa vs Amivantamab: key differentiators?
Rationale for Ficerafusp alfa's new dosing strategy
What signal is needed for CRC/PDAC expansion?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Bicara Therapeutics earnings date
Barclays 28th Annual Global Healthcare Conference10 Mar, 2026
Bicara Therapeutics
Next Bicara Therapeutics earnings date
Barclays 28th Annual Global Healthcare Conference10 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Bicara Therapeutics Inc. is a biopharmaceutical company focused on developing innovative immuno-oncology therapies for cancer treatment. The company specializes in creating biologics that combine tumor-targeting properties with immune modulation to improve treatment outcomes for patients with advanced or resistant cancers. Bicara’s research and development efforts are geared toward creating therapies that harness the body’s immune system to selectively target and combat cancer cells. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage